Login
Toggle navigation
Videos
Categories
Trending
Early-stage fund that wants to be with its founders throughout their journey|Yves Sisteron,Managing Partner,Upfront Ventures
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Managing Partner and Co-Founder at Upfront Ventures.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Dan Symons President & Chief Executive Officer of C3 Metals
00:10:00
Swiss Group Dätwyler Accelerates Growth with New Healthcare Component Plant in USA, Says CEO Lambrecht
00:10:00
The Incredible Journey of Building a Multi-Billion Dollar Enterprise from Humble Beginnings | Alan S. McKim, CEO, Clean Harbors Inc.
00:10:00
CEO Jan Rindbo Presents NORDEN's Q1 2020 Financial Results | Jan Rindbo - CEO of Dampskibsselskabet Norden A/S
00:10:00
Commvault CEO Sanjay Mirchandani discusses how his company has 'democratized' cloud security in a Fortt Knox Update.|Sanjay Mirchandani, has served as our President and Chief Executive Officer of Commvault
00:10:00
MAG Silver Corp: Leading Silver Exploration and Development in Mexico
00:10:00
Atlas Salt Announces "The Great Atlantic Build Team"
00:10:00
Helping founders do exponentially more stuff|Mahdi Raza,Founder,SiberX
00:10:00
"Emerging Market Disruptors: Insights from Cleo Chang, American Century Investments"
00:10:00
working in the digital redesign of the everyday economy, usually before meaningful traction|Rob Go,Co-Founder and Partner,NextView Ventures
00:10:00
The Rise of Decentralized Finance - Framework Ventures|Vance Spencer,Co-Founder,Framework Ventures
00:00:00
Universal Biosensors (ASX:UBI) John Sharman, CEO, Universal Biosensors Inc